➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Merck
McKinsey
Harvard Business School
Baxter

Last Updated: April 22, 2021

DrugPatentWatch Database Preview

Cabergoline - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cabergoline and what is the scope of freedom to operate?

Cabergoline is the generic ingredient in two branded drugs marketed by Actavis Labs Fl Inc, Apotex Corp, Impax Labs Inc, Ingenus Pharms Llc, Ivax Sub Teva Pharms, Mylan, Par Pharm, and Pharmacia And Upjohn, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for cabergoline. Six suppliers are listed for this compound.

Drug Prices for cabergoline

See drug prices for cabergoline

Recent Clinical Trials for cabergoline

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Stanford UniversityPhase 2
Fertility Center of Las VegasPhase 4
Brigham and Women's HospitalPhase 2

See all cabergoline clinical trials

Pharmacology for cabergoline

US Patents and Regulatory Information for cabergoline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ingenus Pharms Llc CABERGOLINE cabergoline TABLET;ORAL 204735-001 Aug 1, 2018 AB RX No Yes   Get Started Free   Get Started Free   Get Started Free
Mylan CABERGOLINE cabergoline TABLET;ORAL 202947-001 Dec 2, 2013 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Par Pharm CABERGOLINE cabergoline TABLET;ORAL 076310-001 Dec 29, 2005 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Apotex Corp CABERGOLINE cabergoline TABLET;ORAL 201503-001 Mar 8, 2013 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Impax Labs Inc CABERGOLINE cabergoline TABLET;ORAL 077843-001 Jul 3, 2007 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Pharmacia And Upjohn DOSTINEX cabergoline TABLET;ORAL 020664-001 Dec 23, 1996 DISCN Yes No   Get Started Free   Get Started Free   Get Started Free
Ivax Sub Teva Pharms CABERGOLINE cabergoline TABLET;ORAL 077750-001 Mar 7, 2007 AB RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Baxter
Medtronic
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.